EISAI TO PRESENT DATA ON LECANEMAB and OTHER ALZHEIMER’S DISEASE RESEARCH AT THE AD/PD™ 2024 ANNUAL MEETING

TOKYO, Feb. 28, 2024 /PRNewswire/ — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today the company will present the latest findings on lecanemab (U.S. brand name: LEQEMBI®), Eisai’s anti-amyloid beta (Aβ) protofibril* antibody for the treatment of…

Europe Binders in Battery Market Research Report 2024-2031 – Opportunities Arising from IoT and AI Integration in Consumer Electronics

DUBLIN, Feb. 28, 2024 /PRNewswire/ — The “Europe Binders in Battery Market: Analysis and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering. The Europe binders in battery market (excluding U.K.) is projected to reach $1,039.2 million by 2031 from $365.1…

L’INITIATIVE OPEN GATEWAY DE LA GSMA SE RENFORCE AVEC DES LANCEMENTS COMMERCIAUX DANS LE MONDE ENTIER, DAVANTAGE D’OPÉRATEURS ET DE NOUVEAUX CANAUX DE COMMERCIALISATION

Plus de 40 réseaux d’opérateurs mobiles sur les cinq continents ont lancé commercialement des services d’API réseau à l’intention de la communauté des développeurs pour libérer le plein potentiel de la 5G BARCELONE, Espagne, 28 février 2024 /PRNewswire/ — La GSMA a souligné aujourd’hui…

RDP Partnered with Bongards to Expand Farmer Opportunities in America’s Heartland

PERHAM, Minn., Feb. 28, 2024 /PRNewswire/ — Rural Development Partners (RDP) was pleased to award Bongards Creameries $20 million in New Markets Tax Credit financing for equipment toward the expansion of their cheese and whey processing facility in Perham, Minnesota. The funding will…

Europe Nucleic Acid Therapeutics CDMO Market Research Report 2024

DUBLIN, Feb. 28, 2024 /PRNewswire/ — The “Europe Nucleic Acid Therapeutics CDMO Market: Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The Europe nucleic acid therapeutics CDMO market was valued at $1.27 billion in 2023 and is expected to…

Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024: PRMT5 Targeted Therapies Clinical Trials by Company, Indication & Phase

DUBLIN, Feb. 28, 2024 /PRNewswire/ — The “Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024” report has been added to ResearchAndMarkets.com’s offering. A comprehensive study, delineating the pioneering developments in the realm of PRMT5 (Protein Arginine…

MWC2024: Huawei veröffentlicht die Lösung “Intelligente Fabrik” und schafft eine bessere, grünere und intelligentere Zukunft

BARCELONA, Spanien, 28. Februar 2024 /PRNewswire/ — Auf dem MWC 2024 stellte Huawei die Intelligente Fabriklösung vor, die Teil der Huawei-Sitzung für Fertigung und Großunternehmen mit dem Titel „Delve into Industries, Creating a Better, Greener, and Smarter Future” war. Auf der Tagung…

Spoločnosť Huawei na summite Huawei Talent Summit oznámila niekoľko iniciatív v oblasti digitálnych talentov na rok 2024

BARCELONA, Španielsko, 28. februára 2024 /PRNewswire/ — Počas MWC 2024 v Barcelone spoločnosť Huawei usporiadala Huawei Talent Summit a oznámila niekoľko iniciatív v oblasti rozvoja talentov vrátane: spustenia prihlášok do globálneho programu ITU-Huawei Generation Connect Young…

Huawei kündigt auf dem Huawei Talent Summit mehrere digitale Talentinitiativen für 2024 an

BARCELONA, Spanien, 28. Februar 2024 /PRNewswire/ — Während des MWC Barcelona 2024 veranstaltete Huawei den Huawei Talent Summit und kündigte mehrere Initiativen zur Talententwicklung an, darunter: der Start der Bewerbungen für das globale ITU-Huawei Generation Connect Young Leadership…

Sprinklr Set to Join S&P SmallCap 600

NEW YORK, Feb. 28, 2024 /PRNewswire/ — Sprinklr Inc. (NYSE:CXM) will replace Veradigm Inc. (NASD:MDRX) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, March 4. Veradigm will be suspended from the Nasdaq Stock Market on February 29 due to non-compliance with…